DON'T MISS : Talking Africa Podcast – Ethiopia: Looming famine in Tigray is the making of 'starvation crimes' says report by WPF

China’s vaccine outreach doesn’t give it an edge across Africa

Eric Olander
By Eric Olander

Managing Editor, The China Africa Project

Posted on Thursday, 18 March 2021 17:23

A batch of Covid-19 vaccines and medical supplies provided to Comoros by the Chinese government arrived in Moroni. (Photo by Ma Haoyu/Xinhua)


There’s growing anxiety in many Western capitals that China’s head start in distributing vaccines to African countries will provide Beijing with a powerful diplomatic advantage.


While there’s no doubt that China’s vaccine donations are well received on the continent, a trio of Africa analysts at the UK-based global risk consultancy Verisk Maplecroft make the case that “China’s vaccine diplomacy in Africa unlikely to be a geopolitical game-changer.”

Three reasons why China’s vaccine outreach probably won’t have a big impact:

  • Preference for bilateral agreements: “Although China repeatedly vaunts the merits of multilateralism, Beijing clearly favours supplying its vaccines through bilateral agreements rather than via multilateral structures…. Beijing’s preference for bilateral deals will likely hinder China’s ability to carve out a dominant role in the region’s immunisation strategy, given that the majority of doses are likely to come through multilateral structures.”
  • Domestic demand: “The Chinese government will need to prioritise vaccine stocks for its domestic immunisation program, as Beijing can ill afford to be seen to be neglecting the home front. This may limit the supply of Covid-19 vaccines it can provide to the region bearing in mind it also has ambitions in other parts of the world.”
  • Competitors: “African governments will likely seek to purchase vaccines from a variety of sources, as rapidly securing the necessary vaccine doses is their foremost priority. They are therefore unlikely to become dependent on a single provider, further limiting China’s influence. Only in exceptional cases such as Congo, Guinea, Senegal, Seychelles and Zimbabwe, do Chinese vaccines make up a significant proportion of the total supply.”

Read the full report on the Verisk Maplecroft website.

This article is published as part of our partnership with The China Africa Project – read the original here.

Understand Africa's tomorrow... today

We believe that Africa is poorly represented, and badly under-estimated. Beyond the vast opportunity manifest in African markets, we highlight people who make a difference; leaders turning the tide, youth driving change, and an indefatigable business community. That is what we believe will change the continent, and that is what we report on. With hard-hitting investigations, innovative analysis and deep dives into countries and sectors, The Africa Report delivers the insight you need.

View subscription options